PB2349: A PHASE 1, OPEN‐LABEL, MULTICENTER, DOSE‐ESCALATION STUDY OF SGR‐1505 AS MONOTHERAPY IN SUBJECTS WITH MATURE B‐CELL MALIGNANCIES

• Published in: HemaSphere Vol. 7; no. S3; pp. e40906a2 - n/a
• Main Authors: Olszewski, Adam, Kahn, David, Yoo, Brian, Nie, Zhe, Krilov, Goran, Tan, Joanne, Wright, Hamish, Weiss, Daniel, Yin, Wu, Akinsanya, Karen
• Format: Journal Article
• Language: English
• Published: Philadelphia, PA Lippincott Williams & Wilkins 08.08.2023; Wiley
• Subjects: Publication Only